H1 (Interim)
ADXN — H1 2026 Financial Report Analysis
Addex's H1 2026 net loss widened 4.3% to CHF 3.46 million, two-thirds of it its share of Neurosterix's losses. Cash was CHF 0.77 million at June 30 before a USD 2.8 million share sale that funds it into Q4 2027.